Richard A Norman

Computational approaches to therapeutic antibody design: established methods and emerging trends

Sebastian Kelm, Alexandre M J J Bonvin, Lucy J. Colwell, 2019, Briefings Bioinform..

Structural approaches to obtain kinase selectivity.

Richard A Norman, A. Ferguson, R. A. Norman, 2012, Trends in pharmacological sciences.

Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors.

Andrew Pannifer, Richard A Norman, J. Breed, 2004, Bioorganic & medicinal chemistry letters.

Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.

Jon Winter, David Whittaker, Gareth Davies, 2012, Journal of medicinal chemistry.

Prevention of MKK6-dependent activation by binding to p38alpha MAP kinase.

Jon Read, Alexander L Breeze, Richard A Norman, 2005, Biochemistry.